My guest today is Dr Daisy Robinton. I met Daisy at Wired Health in London earlier this year where she delivered a tremendous talk about CRISPR-Cas9 and once I heard it, I knew I had to ask her to come here on the program to share her insights and inspiration into the field of bioengineering.
Daisy is a scientist in gene editing at Harvard University studying stem cell biology at the intersection of embryonic development and cancer. Her research focuses on molecular, cellular and developmental biology, and her papers focus on the potential and promise of stem cell research.
In addition to her scientific career, she’s also an entrepreneur. Along with Dr Jack Kriendler, she cofounded Weird and Wonderful, which is a production company where they combine the arts with science to make the story of science entertaining and reach a broader audience. She was recently named one of Forbes 30 under 30 for 2017 (and just in the nick of time – she recently celebrated her 30th birthday!). She’s also a fashion and lifestyle model, promoting brands such as Reebok and Garmin, and she’s given a TedX talk (see the show notes) about the potential of gene therapy in treating aging.
Daisy and I spoke about how new technologies such as CRISPR Cas-9 are accelerating the development of new genetic therapies, and how science and society are responding and adapting to the new possibilities bioengineering technologies present. I really enjoyed this conversation, and I think you will as well.
Links and Resources Mentioned:
- Daisy Robinton at Weird and Wonderful
- Daisy Robinton on LinkedIn
- Daisy Robinton on Twitter @daisyrobinton
- Report by U.S. National Academy of Sciences (NAS) and the National Academy of Medicine on Human Embryo Editing
- Editing Humanity – Article on the Economist
- Human Gene Editing Receives Science Panel’s Support – Article on New York Times
- Digital Health Events
- Dan Kendall @ HealthTechDan
- Dan [@]digitalhealth.com
- Join Digital Health Today